Outbrain Issues Statement Regarding the Events Surrounding Silicon Valley Bank
NEW YORK, March 11, 2023 (GLOBE NEWSWIRE) — Outbrain Inc. (NASDAQ: OB), a leading recommendation platform for the open web, is providing the following statement […]
NEW YORK, March 11, 2023 (GLOBE NEWSWIRE) — Outbrain Inc. (NASDAQ: OB), a leading recommendation platform for the open web, is providing the following statement […]
Recommendation based on a Phase 3 trial demonstrating superior survival outcomes for Libtayo plus chemotherapy compared to chemotherapy alone TARRYTOWN, N.Y., Feb. 24, 2023 (GLOBE […]
If approved, Dupixent would be the first and only targeted medicine in the EU for these young children Recommendation based on a Phase 3 trial in […]
(MENAFN- PR Newswire) Recommendation is based on data from two pivotal trials showing Dupixent significantly improved itch, skin lesions and health-related quality of life in […]
Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis Recommendation is based on data from two pivotal trials showing […]
(MENAFN- PR Newswire) Recommendation based on a Phase 3 Libtayo trial that was first and only to demonstrate significantly improved survival compared to chemotherapy in […]
Recommendation based on a Phase 3 Libtayo trial that was first and only to demonstrate significantly improved survival compared to chemotherapy in the second-line setting […]
Order clomidSatellite PR News (press release)Order clomid, The organisation informed that the recommendation ITU-R M.1850 identifies satellite radio interface specifications for IMT-2000 systems which, …